Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart

Cardiovascular Research

Volumn 45, Issue 3, 2000, Pages 661-670

  Nakamura, Masanori ^a   Wang, Ning Ping ^a   Zhao, Zhi Qing ^a   Wilcox, Josiah N ^a   Thourani, Vinod ^a   Guyton, Robert A ^a   Vinten Johansen, Jakob ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Ischemia; Leukocytes; Preconditioning; Reperfusion

Indexed keywords

PROTEIN BAX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL FUNCTION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE; HEART MUSCLE REPERFUSION; LEUKOCYTE ADHERENCE; MALE; NONHUMAN; PATHOGENESIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; ELECTROPHORESIS, AGAR GEL; HEART; IN SITU NICK-END LABELING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL REPERFUSION INJURY; NEUTROPHIL INFILTRATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS;

EID: 0033984623     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00393-4     Document Type: Article

References (46)

1. Cotran RS, Kumar V, Collins T. Cellular pathology I: Cell injury and cell death. In: Anonymous (editor). Robbins pathologic basis of disease, 6th ed. Philadelphia, PA: W.B. Saunders Company, 1999:1-29.
2. Reimer K.A., Vander Heide R.S., Richard V.J. Reperfusion in acute myocardial infarction: Effect of timing and modulating factors in experimental models. Am J Cardiol. 72:1993;13G-21G.
3. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
4. MacLellan W.R., Schneider M.D. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res. 81:1997;137-144.
5. Haunstetter A., Izumo S. Apoptosis. Basic mechanisms and implications for cardiovascular disease. Circ Res. 82:1998;1111-1129.
6. Cheng W., Kajstura J., Nitahara J.A., Li B., Reiss K., Liu Y., Clark W.A., Krajewski S., Reed J.C., Olivetti G., Anversa P. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res. 226:1996;316-327.
7. Freude B., Masters T.N., Kostin S., Robicsek F., Schaper J. Cardiomyocyte apoptosis in acute and chronic conditions. Basic Res Cardiol. 93:1998;85-89.
8. Bartling B., Holtz J., Darmer D. Contribution of myocyte apoptosis to myocardial infarction? Basic Res Cardiol. 93:1998;71-84.
9. Kajstura J., Cheng W., Reiss K., Clark W.A., Sonnenblick E.H., Krajewski S., Reed J.C., Olivetti G., Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107.
10. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
11. Murry C.E., Jennings R.B., Reimer K.A. Editorial Comment: New insights into potential mechanisms of ischemic preconditioning. Circulation. 84:1991;443-445.
12. DeFily D.V., Chilian W.M. Preconditioning protects coronary arteriolar endothelium from ischemic-reperfusion injury. Am J Physiol. 265:1993;H700-H706.
13. Richard V., Kaeffer N., Tron C., Thuillez C. Myocardial ischemia/reperfusion/PTCA: Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion. Basic Science Reports. Circulation. 89:1994;1254-1261.
14. Gottlieb R.A., Gruol D.L., Zhu J.Y., Engler R.L. Preconditioning in rabbit cardiomyocytes. J Clin Invest. 97:1996;2391-2398.
15. Piot C.A., Padmanaban D., Ursell P.C., Sievers R.E., Wolfe C.L. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation. 96:1997;1598-1604.
16. Misao J., Hayakawa Y., Ohno M., Kato S., Fujiwara T., Fujiwara H. Expression of Bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation. 94:1996;1506-1512.
17. Kirshenbaum L.A., de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation. 96:1997;1580-1585.
18. Yang J.J., Kettritz R., Falk R.J., Jennette J.C., Gaido M.L. Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. Am J Pathol. 149:1996;1617-1626.
19. Zhao Z.Q., Lefer D.J., Sato H., Hart K.K., Jefforda P.R., Vinten-Johansen J. Monoclonal antibody to ICAM-1 preserves postischemic blood flow and reduces infarct size after ischemia-reperfusion in rabbit. J Leukocyte Biol. 62:1997;292-300.
20. McCarthy N.J., Evan G.I. Methods for detecting and quantifying apoptosis. Curr Top Developm Biol. 36:1998;259-278.
21. Buja L.M., Entman M.L. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation. 98:1998;1355-1357.
22. Zhao Z-Q, Nakamura M, Wang N-P, Wilcox JN, Shearer S, Ronson RS, Guyton RA, Vinten-Johansen J. Reperfusion induces myocardial apoptotic cell death. Circulation (Suppl.) 1999;99:I-705 (Abstract).
23. Albertine K.H., Weyrich A.S., Ma X.L., Lefer D.J., Becker L.C., Lefer A.M. Quantification of neutrophil migration following myocardial ischemia and reperfusion in cats and dogs. J. Leukocyte Biol. 55:1994;557-566.
24. Itoh G., Tamura J., Suzuki M., Suzuki Y., Ikeda H., Koike M., Nomura M., Jie T., Ito K. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol. 146:1995;1325-1331.
25. Krajewski S., Krajewska M., Shabaik A., Miyashita T., Reed J.C. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol. 145:1994;1323-1336.
26. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
27. White E. Life, death, and the pursuit of apoptosis. Genes & Development. 10:1996;1-15.
28. Knudson C.M., Korsmeyer S.J. Bcl-2 and bax function independently to regulate cell death. Nat Genet. 16:1997;358-363.
29. Hearse D.J., Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. [Review]. Cardiovasc Res. 26:1992;101-108.
30. Mehta J.L., Nichols W.W., Mehta P. Neutrophils as potential participants in acute myocardial ischemia: Relevance to reperfusion. J Am Coll Cardiol. 11:1988;1309-1316.
31. Mullane K., Engler R. Proclivity of activated neutrophils to cause postischemic cardiac dysfunction: Participation in stunning? Cardiovasc Drugs Ther. 5:1991;915-924.
32. Fliss H., Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 79:1996;949-956.
33. Cohen M.V., Liu G.S., Downey J.M. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation. 84:1991;341-349.
34. Asimakis G.K., Inners-McBride K., Medellin G., Conti V.R. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol. 263:1992;H887-H894.
35. Thourani V.H., Nakamura M., Duarte I.G., Bufkin B.L., Zhao Z.Q., Jordan J.E., Shearer S.T., Guyton R.A., Vinten-Johansen J. Ischemic preconditioning attenuates postischemic coronary artery endothelial dysfunction in a model of minimally invasive direct coronary artery bypass. J Thorac Cardiovasc Surg. 117:1999;383-389.
36. Gross G.J., Auchampach J.A. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 70:1992;223-233.
37. Kaeffer N., Richard V., Francois A., Lallemand F., Henry J.P., Thuillez C. Preconditioning prevents chronic reperfusion-induced coronary endothelial dysfunction in rats. Am J Physiol. 271:1996;H842-H849.
38. Slater A.F.G., Nobel S.I., Orrenius S. The role of intracellular oxidants in apoptosis. Biochim Biophys Acta. 1271:1995;59-62.
39. Cheng W., Li B., Kajstura J., Li P., Wolin M.S., Sonnenblick E.H., Hintze T.H., Olivetti G., Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest. 96:1995;2247-2259.
40. Abello PA, Fidler SA, Bulkley GB, Buchman TG. Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch.Surg. 1994;129:134-140; discussion 140-1.
41. Ambrosio G., Zweier J.L., Becker L.C. Apoptosis is prevented by administration of superoxide dismutase in dogs with reperfused myocardial infarction. Basic Res Cardiol. 93:1998;94-96.
42. Ono K., Matsumori A., Shioi T., Furukawa Y., Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts. Possible implication in left ventricular remodeling. Circulation. 98:1998;149-156.
43. Solary E., Dubrez L., Eymin B. The role of apoptosis in the pathogenesis and treatment of diseases. Eur Respir J. 9:1996;1293-1305.
44. Baghelai K., Graham L.J., Wechsler A.S., Jakoi E.R. Cardiopulmonary support and physiology. Delayed myocardial preconditioning by α1-adrenoceptors involves inhibition of apoptosis. J Thorac Cardiovasc Surg. 117:1999;980-986.
45. Kida M., Fujiwara H., Ishida M., Kawai C., Ohura M., Miura I., Yabuuchi Y. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation. 84:1991;2495-2503.
46. de Albuquerque C.P., Gerstenblith G., Weiss R.G. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ Res. 74:1994;139-150.